The Advanced Medical Technology Association (AdvaMed) and Biocom, the association representing the California life science industry, have announced a joint partnership to collaboratively produce The Digital MedTech Conference 2020. In combining Biocom’s DeviceFest and Digital Health Conference with AdvaMed’s Digital MedTech Conference, the single event will highlight the evolving digital medtech landscape and explore trends impacting the industry, all while bringing together key leaders from California and beyond.
Business Development Executive
Tony Grover is a business development executive with over twenty years of experience focused on marketing, reimbursement, and commercial strategy for early stage companies. He is the current Chairman of the BIOCOM Medical Device and Diagnostics Committee. He served as Vice President of Business Development for Banyan Biomarkers, the first company to receive FDA approval for a blood test to diagnose mild TBI, or concussion. Prior to Banyan Biomarkers he was the Director of Marketing and Reimbursement at PhotoThera, a privately held medical device company that raised over $100M for the treatment of ischemic stroke. Prior to joining PhotoThera, Mr. Grover was a management consultant for Pittiglio Rabin Todd & McGrath (PRTM), now PwC, where he worked with a variety of Fortune 500 companies to increase operational efficiency. Mr. Grover is currently on the Advisory Board of the Global Brain Health Coalition that brings brain health awareness to patients, athletes, veterans, and caregivers. Mr. Grover previously served on the Board of Directors for the American Heart Association, San Diego from 2010-2012, as Chairman from 2012-2014, and as Past Chair in 2015.
Three innovative companies will have the opportunity to give their five-minute pitches to a panel of judges and investors at the conference, while receiving on-the-spot critiques. This hot seat is a fast, fun, and interactive forum, giving entrepreneurs the opportunity to pitch their technologies in front of world-class leaders and investors. Voted on by audience […]